Design. Formulate. Deliver.

ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the formulation, analytical and process development, sterile manufacturing (fill&finish), and testing of tomorrow’s medicines. We support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients.

As a CDMO for the pharma industry, ten23 health combines the latest scientific findings with our proven and tested world-class industry and regulatory expertise to forge new paths for our clients’ needs. From our locations in Basel and Visp, Switzerland, we provide our innovative services to pharmaceutical companies around the world in a fair and sustainable manner, respecting people’s health and the future of our planet.

 
Development_Strategy

Development
Strategy

Formulation_Development

Formulation
Design

Administration_Compatibility_Usability

Administration,
Compatibility & Usability

Drug_Device_Integration

Drug/Device
Integration

Molecule_Selection_Characterization

Molecule Selection &
Characterization

Analytical_Development_Testing

Analytical Development &
Testing

Packaging_Device

Packaging &
Device Characterization

Molecules_Supported

Molecules
Supported

Troubleshooting_Regulatory_Support

Troubleshooting &
Regulatory Support

Manufacturing_Process_Transfer

Manufacturing Process Transfer,
Characterization and Validation

Clinical_Fill_Finish_Commercial_Supplies

Clinical Fill & Finish
and Commercial Supplies

Stability_Preclinical_Supplies

Stability &
Pre-clinical Supplies

Patients, People,
Planet

Our team at ten23 health is strongly purpose-driven. We put Patients, People and Planet at the center of our decisions and actions.

We take pride in being the first CDMO in the pharmaceutical industry for injectables/sterile drug products to have been certified as a B Corp.

Read the newest ten23 Fairstainabiity Report to find out more on our achievements and sustainability certifications in 2024.

 
 

The Team

We are combining world-class expertise in science, development, and regulatory requirements to best support the development of innovative healthcare solutions. 

Interested to learn more about ten23 health?

Press releases

Press Releases

ten23 health’s Fairstainability Impact Report 2024 confirms its position as a world leader in sustainable pharma manufacturing

Basel, 2 of April 2025: ten23 health is proud to announce a range of achievements and sustainability certifications, with the publication of its yearly Fairstainabilty Report.

Download Press Release

Press Releases

ten23 health and BD partner to advance efficiency and quality in aseptic manufacturing with RFID-enabled prefillable syringes

Basel, 7 of October 2024: ten23 health and BD (Becton, Dickinson and Company) (NYSE: BDX), today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

Download Press Release

Press Releases

ten23 health hosts Grand Opening of its State-of-the-Art VIVA2® Sterile Manufacturing Facility in Visp, Switzerland

Visp, 24 of September 2024: The event marks a significant milestone in the company's growth, as the newly constructed VIVA2® facility is one of the most advanced and energy efficient of its kind

Download Press Release

Press Releases

ten23 health achieves its certification as a B Corporation, recognizing its commitment to social and environmental responsibility and sustainability

Basel, 16 of September 2024: ten23 health is proud to announce its official certification as a B Corporation (B Corp). ten23 health is the first biotech and sterile drug product CDMO in the pharmaceutical sector to achieve B Corp certification, which recognizes its dedication to meeting rigorous standards of social and environmental performance, accountability, and transparency.

Download Press Release

Press Releases

ten23 health® publishes its 2023 Fairstainability Impact Report and reports major progress on its Sustainability Goals

Basel, 22 of April 2024: ten23 health recognizes the importance of environmental stewardship, social responsibility, and its goal of driving positive change in the pharmaceutical and CDMO industry. The 2023 Fairstainability Impact Report transparently provides the status and progress towards achieving ten23´s sustainability goals.

Download Press Release

Download Report

Press Releases

ten23 health® and Ypsomed collaborate for the commercialization of patch injector

Burgdorf & Basel, 16 of April 2024. ten23 health® and Ypsomed, a leader in developing and manufacturing the new generation of patient-friendly injection and infusion systems, accounted today entering into partnership. The aim of this collaboration is to advance the commercialization of the YpsoDose wearable injector for the subcutaneous self-injection of large-volume doses. ten23’s drug development, filling and device assembly expertise will significantly contribute to the product offering.

Download

Press Releases

ten23 health® and SHL Medical announce a strategic partnership agreement for integrated services.

Basel, Switzerland, 25 of March 2024: ten23 health®, the Swiss contract development and manufacturing organization (CDMO) for sterile drugs, and SHL Medical, a world-leading provider of drug delivery devices, today announced their strategic partnership to provide a streamlined offering for pharmaceutical and biotech companies that require sterile drug/device combination products.

Download

Press Releases

ten23 health´s VIVA2 large-scale pre-filled syringe, cartridge, and vial aseptic Filling Line 2 in Switzerland GMP operational by end 2024

Basel, Switzerland, 18 of March 2024. ten23 health®, the Swiss contract development and manufacturing organization, today accounted that its VIVA2 aseptic large-scale pre-filled syringe (PFS), vial and cartridge Filling Line 2 will be GMP operational by the end of 2024.

Download

Press Releases

On eve of CPHI Hanns-Christian Mahler stresses the importance of holistic sterile drug product development

Basel, 23rd of October 2023: On the eve of CPHI, ten23 health®, a global contract development and manufacturing organization, today announced that CEO Hanns-Christian Mahler will give a webinar stressing the importance of holistic sterile drug product development.  

Download

You missed the webinar? You can rewatch it here

Press Releases

ten23 health announces the successful implementation and certification of the ISO 9001:2015 Quality Management for its Development services in Basel.

Basel, 11th of September 2023. ten23 health® is happy to announce this implementation. Using ISO 9001 helps ensure that customers get consistent, good-quality products and services.

Download

Press Releases

ten23 health expands sterile manufacturing capacity at its VIVA 1® facility through completion of its first expansion and the introduction of an additional shift

Basel, 4th of September 2023. ten23 health® announces a capacity expansion for the manufacture of sterile drug product at its Visp facility. This will help to meet rapidly increasing customer demand.

Download

Press Releases

ten23 health announces expansion with the launch of quality control services

July 10th, 2023 - ten23 health® announces the launch of “quality control” (QC) service offerings in Switzerland for release and stability testing of clinical and commercial sterile drug products according to international cGMP standards.

Download

/

Customer Feedback on our Swiss Quality Services

Technical knowledge, expertise, and skills; proactive communication, excellent presentations and explanations/clarifications, prompt completion of tasks, always within scheduled timelines, willingness to adjust and adapt work efforts as needed and in a timely manner.

CEO, Biotech

 

 

We really appreciate the collaborative atmosphere of working with ten23. While the ten23 technical team is highly knowledgeable, logical in their thinking, and decisive in their decision making, we have found the ten23 team to be very accommodating in their willingness/openness to discuss alternatives and work together to identify the best solution that is mutually acceptable to both parties. This is invaluable to us and we believe your team excels at this.
(This is not always the case with even some of the "best" contract manufacturers. I am sure this is true for many customers as well).

Project Lead, Top-Ten Pharma

 

 

The ten23 team did an excellent job of running the study to a very high quality and delivering fully qualified data to us on time. I was really impressed with how seamlessly this was managed without any hiccups. I am happy to work with such a great team that knows how to meet expectations and deliver high quality performance.
A big bow!

Project Lead, Top-Ten Pharma

 

 

Upcoming events

Pharmapack

Paris, France

January 22, 2025

DCat

New York City, USA

March 16, 2025

Bio-Europe Spring

Milan, Italy

March 17, 2025

PDA Parenteral Packaging Conference 2025

Malaga, Spain

March 25, 2025

Consortium Mibi KAU

Kaiseraugst, Germany

March 30, 2025

FHNW Future Day

FHNW Campus Muttenz, Switzerland

April 02, 2025

PDA Annual Event

Palm Springs, CA, USA

April 06, 2025

Festival of Biologics

San Diego, USA

April 23, 2025

SAE’s Pre-Filled Syringes and Injectable Drug Devices conference

Boston, USA

April 28, 2025

Swiss Biotech Day

Basel, Switzerland

May 05, 2025

CDMO live

Rotterdam, Netherlands

May 07, 2025

ISPE Europe

London, United Kingdom

May 12, 2025

CPhI North America

Pennsylvania, USA

May 20, 2025

PDA Good aseptic manufacturing

Basel, Switzerland

May 22, 2025

The Pharma Days

Geneva, Switzerland

June 04, 2025

BOS 2025

Basel, Switzerland

June 11, 2025

Bio International Convention

Boston, USA

June 16, 2025

London Biotechnology Show

London, United Kingdom

June 18, 2025

GMP compliance

Copenhagen, Dennmark

June 26, 2025

On Helix

Cambridge, United Kingdom

July 03, 2025

CE Pharm

Bethesda, MD, USA

September 07, 2025

Biotech Week

Boston, USA

September 15, 2025

Chemie und Life Science Event in Basel | Ilmac

Basel, Switzerland

September 16, 2025

Website ⟶

Contract Pharma Conference

New Brunswick, USA

September 18, 2025

Festival of Biologics

Basel, Switzerland

September 30, 2025

Fierce Biotech week

Boston, USA

October 07, 2025

BioJapan

Yokohama, Japan

October 08, 2025

PDA Universe of Pre-Filled Syringes and Injection Devices

Vienna, Austria

October 21, 2025

Cphi worldwide

Frankfurt, Germany

October 28, 2025

Bio Europe

Vienna, Austria

November 03, 2025